Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: J Thorac Oncol. 2012 Aug;7(8):1211–1217. doi: 10.1097/JTO.0b013e318257cc89

Figure 2.

Figure 2

MK-8033 radiosensitizes EBC-1 and H1993 cells but not A549 and H460 NSCLC cells. A 1-hour pretreatment with MK-8033 (1 μM) radiosensitized NSCLC cells with high basal c-Met levels (EBC-1 and H1993) but not in low c-Met-expressing cells.